4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-019040
President & CEO bought 4,000 shares at $3.91 ($15,647)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| USMAN NASSIM President & CEO | 2020-03-13 | Purchase | +4,000 | $3.91 | $15,647 | 11,010 | D: show line 1 in the form |
| Open-market purchases · 4,000 sh · avg $3.91 · $15,647 | |||||||
Loading xslF345X03/doc4.xml…